Skip to content

Optimizing treatment in digestive psychosomatic diseases with circadian rhythm disorders

CTX preconditioning mediated NDRG2 involvement in chronic visceral pain - central sensitization through EAAT2 and its mechanism

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052479
Enrollment
Unknown
Registered
2021-10-28
Start date
2021-10-29
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive psychosomatic disease/Functional Gastrointestinal Disease/Gastrointestinal Motility Disorder

Interventions

control group:conventional therapy
Test group:Flupentixol-melitracen combined conventional treatment

Sponsors

Department of Gastroenterology, Army Medical Center of PLA, Daping Hospital, Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Male or female, aged 18 to 75 years; 2. No acid suppression treatment, no sedative, sleep, anti-anxiety and depression drugs within 2 weeks; 3. Diagnosis of gastroesophageal reflux disease (Gerd>=Q8 points; gastroscope indicates reflux esophagitis, Barrett's esophagus; pH measurement indicates acid reflux; any of the above conditions are met); 4. Hamilton anxiety or depression score >= 7 points; 5. Sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with hyperthyroidism and other diseases that obviously change the indicators of the brain-gut axis; 2. Patients with known gastrointestinal tumors and severe gastrointestinal ulcers; 3. Samples that do not meet the requirements for sample collection and processing; 4. The test result is missing the test result of the test reagent (or comparative method); 5. During the test, the test results were recorded incorrectly, and the source could not be traced.

Design outcomes

Primary

MeasureTime frame
Cortisol;Thyroid function;Fasting blood glucose;Adrenocorticotropic hormone;

Countries

China

Contacts

Public ContactYang Min

Army Medical Center of PLA, Daping Hospital, Army Medical University

yangmindoctor@126.com+86 18983098877

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026